Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium.
Department of Nephrology, Antwerp University Hospital, Edegem, Belgium.
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):454-468. doi: 10.2215/CJN.08020718. Epub 2019 Jan 2.
MicroRNAs are epigenetic regulators of gene expression at the posttranscriptional level. They are involved in intercellular communication and crosstalk between different organs. As key regulators of homeostasis, their dysregulation underlies several morbidities including kidney disease. Moreover, their remarkable stability in plasma and urine makes them attractive biomarkers. Beyond biomarker studies, clinical microRNA research in nephrology in recent decades has focused on the discovery of specific microRNA signatures and the identification of novel targets for therapy and/or disease prevention. However, much of this research has produced equivocal results and there is a need for standardization and confirmation in prospective trials. This review aims to provide an overview of general concepts and available clinical evidence in both the pathophysiology and biomarker fields for the role of microRNA in AKI and kidney transplantation.
微小 RNA 是在后转录水平上对基因表达进行表观遗传调控的一类物质。它们参与细胞间的通讯以及不同器官之间的串扰。作为内稳态的关键调节因子,它们的失调是包括肾脏疾病在内的多种疾病的基础。此外,它们在血浆和尿液中具有显著的稳定性,这使它们成为有吸引力的生物标志物。除了生物标志物研究,近几十年来肾脏病学中的临床微小 RNA 研究集中在发现特定微小 RNA 特征以及鉴定新的治疗和/或疾病预防靶点上。然而,这项研究的大部分结果都存在争议,需要在前瞻性试验中进行标准化和确认。这篇综述旨在概述微小 RNA 在急性肾损伤和肾移植中的作用在病理生理学和生物标志物领域的一般概念和现有临床证据。